Augmedix, Inc. - stock earnings
AUGX Quarterly earnings
Date | Earnings | Revenue |
---|---|---|
2023Q4 | -4.5 million USD | 12.7 million USD |
2023Q3 | -4.4 million USD | 11.8 million USD |
2023Q2 | -5.0 million USD | 10.8 million USD |
2023Q1 | -5.3 million USD | 9.6 million USD |
2022Q4 | -5.6 million USD | 8.8 million USD |
2022Q3 | -5.5 million USD | 7.9 million USD |
2022Q2 | -8.8 million USD | 7.3 million USD |
2022Q1 | -5.9 million USD | 7.0 million USD |
2021Q4 | -5.5 million USD | 6.6 million USD |
2021Q3 | -2.9 million USD | 5.6 million USD |
2021Q2 | -4.6 million USD | 5.2 million USD |
2021Q1 | -4.9 million USD | 4.8 million USD |
2020Q4 | -3.8 million USD | 4.5 million USD |
2020Q3 | -4.1 million USD | 4.2 million USD |
2020Q2 | -3.0 million USD | 3.7 million USD |
2020Q1 | -4.7 million USD | 4.0 million USD |
AUGX Yearly earnings
Date | Earnings | Revenue |
---|---|---|
2023 | -19.2 million USD | 44.9 million USD |
2022 | -26.5 million USD | 30.9 million USD |
2021 | -17.2 million USD | 22.2 million USD |
2020 | -14.7 million USD | 16.5 million USD |
2019 | -22.4 million USD | 14.1 million USD |
2018 | -24.2 million USD | 10.8 million USD |
AUGX
Price: $2.72
52 week price:
Earnings Per Share: -0.50 USD
P/E Ratio: -8.68
Exchange: NCM
Sector: Healthcare
Industry: Health Information Services
Volume: 112500
Market Capitalization: 195.7 million